|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:activities
|
gptkb:physicist
|
|
gptkbp:appearance
|
colorless liquid
|
|
gptkbp:appointed_by
|
subcutaneous injection
|
|
gptkbp:approves
|
gptkb:2010
|
|
gptkbp:brand
|
gptkb:Victoza
|
|
gptkbp:clinical_trial
|
Phase 3
weight management
ongoing research
glycemic control
|
|
gptkbp:color
|
clear
|
|
gptkbp:contraindication
|
gptkb:multiple_endocrine_neoplasia_syndrome_type_2
gptkb:medullary_thyroid_carcinoma
|
|
gptkbp:dosage_form
|
solution for injection
|
|
gptkbp:duration
|
as prescribed by physician
|
|
gptkbp:education
|
important for safe use
|
|
gptkbp:effective_date
|
2010-01-25
|
|
gptkbp:feedback
|
generally positive
|
|
gptkbp:formulation
|
pre-filled pen
|
|
gptkbp:frequency
|
once daily
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Victoza
|
|
gptkbp:ingredients
|
gptkb:liraglutide
|
|
gptkbp:interacts_with
|
gptkb:Company
sulfonylureas
other GLP-1 receptor agonists
|
|
gptkbp:is_monitored_by
|
gptkb:weight
renal function
blood glucose levels
|
|
gptkbp:is_used_for
|
obesity
type 2 diabetes
|
|
gptkbp:manager
|
subcutaneous
|
|
gptkbp:manufacturer
|
gptkb:Novo_Nordisk
|
|
gptkbp:marketed_as
|
gptkb:legislation
gptkb:United_States
gptkb:Native_American_tribe
|
|
gptkbp:packaging
|
single-use pen
|
|
gptkbp:population
|
adults
pediatric patients over 10 years old
|
|
gptkbp:previous_name
|
gptkb:battle
|
|
gptkbp:price
|
varies by region
|
|
gptkbp:provides_information_on
|
recommended for certain patients
|
|
gptkbp:requires
|
available online
|
|
gptkbp:research
|
published in medical journals
|
|
gptkbp:safety_features
|
required post-marketing
|
|
gptkbp:scholarships
|
available through manufacturer
|
|
gptkbp:side_effect
|
headache
nausea
vomiting
diarrhea
hypoglycemia
pancreatitis
kidney injury
|
|
gptkbp:storage
|
refrigerated
|
|
gptkbp:treatment
|
reduce body weight
improve glycemic control
|
|
gptkbp:type_of_care
|
important for efficacy
|
|
gptkbp:type_of_insurance
|
may vary
|
|
gptkbp:website
|
upper arm
thigh
abdomen
|
|
gptkbp:bfsParent
|
gptkb:liraglutide
|
|
gptkbp:bfsLayer
|
6
|